• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Vas destroyed CV

anonymous

Guest
Ever since dumb vas and take it deep Sandeep joined, it’s been going downhill. They got rid of the smaller people. And still decide to keep the stupid way way over paid incompetent upper management morons
 




Reject from New Deli has doomed CV w/ Leqvio acquisition for $9.4 BILLION!

NEVER will become profitable.
NEVER will break even.

CV is DOOMED.

Time to open a Kwik-E-Mart w/ my neighbor Apu.
 




Reject from New Deli has doomed CV w/ Leqvio acquisition for $9.4 BILLION!

NEVER will become profitable.
NEVER will break even.

CV is DOOMED.

Time to open a Kwik-E-Mart w/ my neighbor Apu.

lmao what an idiot he is, spending over 9 billion on Leqvio. It’s a failed drug and it’ll continue to fail more and more. Vas and Sandeep would have more luck selling slurpees at 711